Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025

Data from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MIMilad IbrahimIIIrineu Illa-BochacaGJGeorge Jour

Discussion

Loading...

Member takes

Overview

Observational analysis detects heightened EGFR expression in NF1-mutant melanoma, suggesting targeted EGFR inhibitors may improve patient outcomes.

Key Points

  • EGFR activation drives proliferation and survival in NF1-mutant melanoma cells, leading to growth.
  • Inhibition of EGFR reduces growth in NF1-mutant models but not in wild-type models, highlighting treatment implications.
  • Patient-derived cultures reveal the significance of NF1 loss in strengthening reliance on EGFR signaling pathways.
  • Findings support testing EGFR inhibitors like cetuximab in clinical trials for patients with NF1-mutant melanoma.

Cite This Study

Ibrahim et al. (2025) studied this question.

synapsesocial.com/papers/68c23a2cb210217d6477fbdfhttps://doi.org/10.1158/0008-5472.c.8012153
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Figure S5 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  2. 2Figure S2 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  3. 3Figure S3 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  4. 4Tables S1 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  5. 5Table S2 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025